Takeda appoints new Area Head for India, C.I.S., Middle East, Turkey, and Africa. Dr.Mahender Nayak , proven leader with more than 20 years of experience in biopharmaceutical industry will continue to increase patient access to Takeda’s portfolio of highly innovative medicines.
Delhi : Takeda Pharmaceutical Company Limited (“Takeda”), has announced the appointment of Dr.Mahender Nayak as Area Head for the Company’s ICMEA (India, C.I.S., Middle East, Turkey, and Africa) Area. In his current capacity, Dr. Nayak will lead the company’s operations from Dubai, United Arab Emirates (U.A.E.), where he will be based.
Commenting on his new role, Dr. Nayak said, “This is an exciting time to move to a part of the worldthat is teeming with great opportunities to increase patient access to Takeda’s highly innovative medicines. We aim to do this through our commercial activities and commitments around our approaches to Access to Medicines across rare diseases, oncology, neuroscience,and gastroenterology.”
Dr. Nayak started his career as a physician in Bangalore, India and has an MBA in Marketing. He joined Takeda in 2011 and, since then, grew within the company to hold various senior international and regional roles.